Marcaine Injectable Product
Post-Operative Pain, Chronic
Loyola UniversityPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Post-Operative Pain, Chronic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Archit Sharma | Phase 2 | B |
Calcium hydroxide Cairo University | N/A | D |
Same molecule, other indications
Marcaine Injectable Product is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →